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Abstract
Ankrd1/CARP, Ankrd2/Arpp, and Ankrd23/DARP belong to a family of stress inducible ankyrin repeat proteins expressed in
striated muscle (MARPs). The MARPs are homologous in structure and localized in the nucleus where they negatively
regulate gene expression as well as in the sarcomeric I-band, where they are thought to be involved in mechanosensing.
Together with their strong induction during cardiac disease and the identification of causative Ankrd1 gene mutations in
cardiomyopathy patients, this suggests their important roles in cardiac development, function, and disease. To determine
the functional role of MARPs in vivo, we studied knockout (KO) mice of each of the three family members. Single KO mice
were viable and had no apparent cardiac phenotype. We therefore hypothesized that the three highly homologous MARP
proteins may have redundant functions in the heart and studied double and triple MARP KO mice. Unexpectedly, MARP
triple KO mice were viable and had normal cardiac function both at basal levels and in response to mechanical pressure
overload induced by transverse aortic constriction as assessed by echocardiography and hemodynamic studies. Thus, CARP,
Ankrd2, and DARP are not essential for normal cardiac development and function at basal conditions and in response to
mechanical pressure overload.
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Introduction
In cardiac and skeletal muscle, a family of muscle specific
ankyrin repeat proteins (MARPs) includes cardiac ankyrin repeat
protein (CARP/Ankrd1) [1,2,3,4], Ankyrin repeat domain protein
2 (Ankrd2/Arpp) [5,6], and diabetes related ankyrin repeat
protein (DARP/Ankrd23) [7]. The three proteins share ,50%
sequence identity and all contain a N-terminal nuclear localization
signal and four ankyrin repeats [8]. CARP is mainly expressed in
cardiac muscle, Ankrd2 in skeletal muscle, and DARP at similar
amounts in both cardiac and skeletal muscle; however all three
proteins can be induced both in heart and skeletal muscle in
response to various forms of stress. All three MARPs are localized
in the nucleus as well as the sarcomeric I-band where they bind to
the titin N2A region between the two principal spring elements,
the tandem immunoglobulin (Ig) and PEVK spring regions,
suggesting their role in stretch/stress sensing [8].
Cardiac ankyrin repeat protein (CARP) was first identified as a
cytokine-inducible gene in microvascular endothelial cells [2] and
later recognized as a cardiac doxorubicin responsive nuclear
transcription factor downstream of the Nkx2.5 pathway [3,4].
CARP is highly expressed in the early embryonic heart and is
downregulated to lower levels in adult heart. However, during
postnatal hypertrophy induced by mechanical pressure overload
or a1-and b-adrenergic agonist stimulation in animal models,
CARP is markedly induced, suggesting that it is a member of the
hypertrophic embryonic gene program [9,10,11,12,13,14,15].
Likewise, CARP is induced in patients with hypertrophic, dilated,
ischemic, and arrhythmogenic right ventricular cardiomyopathy
[16,17,18] and missense mutations in the Ankrd1 gene were
recently shown to be causative for human dilated and hypertro-
phic cardiomyopathy [19,20,21]. Further evidence supporting an
important role of CARP in regulating the cardiac hypertrophic
response comes from a recent study of cardiac-specific CARP-
overexpressing transgenic mice, which were found to show an
attenuated cardiac hypertrophic response following mechanical
pressure overload or isoproterenol infusion [22]. In in vitro studies,
CARP has been shown to bind to the ubiquitous Y-box
transcription factor 1 (YB-1) and act as a nuclear transcriptional
cofactor by negatively regulating the expression of cardiac genes,
including the ventricular specific myosin light chain-2v, atrial
natriuretic factor, and cardiac troponin C [3,4,12]. Furthermore,
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knockdown of CARP in rat cardiomyocytes resulted in sarcomere
disarray and inhibition of myofilament gene transcription [23].
CARP can bind to both the titin N2A region and myopalladin in
the I-band, suggesting its role in mechanosensing and regulation of
gene expression in response to muscle stress [8,24]. In addition,
CARP has been shown to be able to dimerize and bind to desmin,
the muscle specific RING finger proteins MuRF1 and MuRF2,
cardiac calsequestrin 2 [25,26,27], and the tumor suppressor
protein p53 [28], suggesting a versatile role of CARP in the heart.
Ankyrin repeat protein 2 (stretch responsive-muscle) (Ankrd2)/
Ankyrin Repeat protein with PEST and Proline-rich region (Arpp)
was first described by Kemp as a striated muscle specific gene
induced by mechanical stretch and involved in mechanically-
induced skeletal muscle hypertrophy [5]. Further studies revealed
that Ankrd2 is selectively expressed in type I fibers of skeletal
muscle muscle [29,30] and present only at low levels in the left and
right ventricles, the interventricular septum, and the apex of the
heart [6]. During fetal development Ankrd2 is diffusely expressed
in skeletal muscles and is barely detectable in the heart [29]. Like
CARP, Ankrd2 is highly responsive to acute stress and has been
found to be upregulated during myoblast differentiation [29] and
in response to mechanical muscle stretch [5,31], exercise [32],
eccentric contractions [33,34], and denervation [35]. Further-
more, Ankrd2 has been shown to translate to the nuclei in
myofibers in the vicinity of injured fibers [36]. In human, Ankrd2
is upregulated in congenital myopathies [37] and downregulated
in muscular dystrophy [30,37] and show an altered expression
pattern in spinal muscular atrophy and amylotrophic lateral
sclerosis [30,37,38], likely due to changes in fiber type distribution
[39]. Furthermore, Ankrd2 was found to be upregulated in human
dilated cardiomyopathy [16], suggesting that Ankrd2 may also be
involved in cardiac pathologies. In addition to the titin N2A
domain, Ankrd2 has been shown to interact with T-cap/telethonin
as well the transcription factors YB-1, promyelocytic leukemia
protein (PML), and p53, suggesting that Ankrd2 may also be
involved in muscle gene regulation [40]. Furthermore, our recent
results have demonstrated that Akt2-phosphorylated Ankrd2 can
bind directly to the NF-kB p50 subunit and negatively regulate
inflammatory responses during muscle differentiation in response
to oxidative stress [41].
Diabetes-related ankyrin repeat protein (DARP) is expressed in
heart, skeletal muscle, and brown adipose tissue [7] and is the least
studied of the three proteins. It was found to be upregulated in the
hearts of type 2 diabetic and insulin resistant mice and to show
altered expression after metabolic challenge, suggesting its
potential role in energy metabolism [7].
Taken together, several lines of evidence suggest that the
MARPs belong to a family of stress responsive proteins, which
plays critical roles in the heart. However, although the MARPs
have been extensively studied, their functional role in the heart
in vivo remains unknown. To address this, we studied knockout
(KO) mice for each of the three MARP family members. All three
KO mouse models are viable and have no apparent cardiac
phenotype, which we hypothesized might be due to redundant
functions of the highly homologous MARP proteins. We therefore
studied double (CARP/Ankrd2, CARP/DARP, and Ankrd2/
DARP) and triple (CARP/Ankrd2/DARP) MARP KO mice, but
to our surprise both double and triple KO mice were viable and
extensive analyses up to 17 months of age did not reveal any
abnormalities in cardiac development or function, either at
baseline or in response to biomechanical stress induced by
pressure overload hypertrophy. Thus, our results suggest that
CARP, Ankrd2, and DARP are not required for normal cardiac
development and function at basal conditions and in response to
mechanical pressure overload in vivo.
Materials and Methods
Ethics Statement
All animal procedures were approved by the University of
California San Diego Animal Care and Use Committee (Approval
reference number: S01049) and performed in full compliance with
the guidelines of the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996). Special attention was paid to
animal welfare and to minimize the number of animals used and
their suffering.
Generation of Single, Double, and Triple MARP KO Mice
Although the analysis of the skeletal muscle phenotype of
MARP triple KO mice has been published [42], the generation of
the KO mice has not previously been described in detail. Genomic
DNA clones were isolated from a mouse 129/SvJ genomic DNA
library (Stratagene, La Jolla, CA), using full-length cDNA of
CARP, Ankrd2, and DARP, respectively. The first 2–3 exons of each
gene were replaced by cDNA encoding lacZ and a pGK neo
cassette. In this manner, the b-galactosidase cDNA was brought
under the control of the endogenous promoters, while also
ablating the endogenous CARP, Ankrd2, and DARP genes,
respectively. The generation of Ankrd2 KO mice has been
described previously [41]. The targeting constructs were verified
by sequencing and linearized before electroporation into 129/SvJ-
derived ES cells at the Transgenic Core Facility at the University
of California, San Diego. ES clones were screened for homologous
recombination by Southern blot analysis with probes as shown in
Fig. 1A, E, and Bean et al [41]. Cells from two independent
targeted clones from each construct were microinjected into
C57BL/B6 blastocysts and transferred into pseudopregnant mice.
Male chimeras resulting from the microinjections were bred with
female Black Swiss mice to generate germ line transmitted
heterozygous mice. These were subsequently intercrossed to
generate homozygous mice. Offspring from intercrosses were
genotyped by PCR analysis using mouse tail DNA and wildtype
(WT) and mutant allele specific primers. The following primers
were used: CARP WT (sense: ATAGACTCACGGCTGCCAA-
CAT; reverse: CTCCATTTCTGAACTCCCCAGG), mutant
(sense: TGGGATGACTCGCATTGCTGAG; reverse: AGAT-
GAAACGCCGAGTTAACGC); Ankrd2/Arpp WT (sense:
AACTTCGAAGATCCGCTCCTGG; reverse: CATCAAT-
GATCTCACGTCGCAG), mutant (sense: CACACTGGA-
CAGGCCTCTTTCC; reverse: AGATGAAACGCCGAGT-
TAACGC); DARP WT (sense:
GCAGTTGGTAAGGATGTGAGGA; reverse: TCCAA-
CAAGGGCAAACCTACAA), mutant (sense: CCTGGGCA-
CAAGCTTTGTCCTT; reverse: AGATGAAACGCCGAGT-
TAACGC). Double and triple MARP KO mice were generated
by interbreeding of single KO mice. To ensure that WT control
mice had the same genetic background as double and triple
MARP KO mice, also WT mice were generated from the crosses.
Protein Isolation and Western Blot Analysis
Animals were anaesthetized by intraperitoneal injection of a
mixture of ketamine (100 mg/kg) and xylazine (5 mg/kg) and
sacrificed by cervical dislocation before removal of tissues. Total
protein extracts were prepared from heart and skeletal muscle [43]
and subjected to Western blot analysis using polyclonal antibodies
against CARP and DARP (5 mg/ml, described in Miller et al. [8]).
The MARPs Are Not Essential for Cardiac Function
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Gluceraldehyde-3-phophate dehydrogenase (GAPDH) antibody
was used for normalization (1:1000; Sigma-Aldrich).
Histology
Dissected mouse hearts were fixed with 4% paraformaldehyde
followed by dehydration and paraffin embedding. 10 mm sections
were stained with hematoxylin and eosin or by Masson’s trichrome
method.
Cardiac Functional Studies
For transthoracic echocardiography, mice were anesthetized
with 1% isoflurane and imaged as previously described [44]. For
surgical procedures, mice were anaesthetized by intraperitoneal
injection of a mixture of ketamine (100 mg/kg) and xylazine
(5 mg/kg) and anesthesia depth was monitored by toe pinching.
Cardiac hemodynamic parameters were evaluated in 8-week-old
female and 17-month-old male mice by insertion of a 1.4 French
Millar catheter-tip micromanometer catheter through the right
carotid artery into the left ventricle [10]. Pressure was recorded
both and baseline and following stimulation with graded doses of
the b-adrenergic agonist dobutamine (0.75, 2, and 4 mg/kg/min)
as previously described [10]. Transverse aortic constriction (TAC)
was performed with a 27-gauge needle on 17 to 18-week-old male
mice as described elsewhere [44]. 14 days after TAC, cardiac
morphology and function was evaluated by echocardiography and
Figure 1. Generation of CARP and DARP KO mice. (A, E) Targeting strategies. Restriction maps of relevant genomic regions of Ankrd1 (A) and
Ankrd23 (E) are shown on top, targeting constructs are shown in the center, and mutated loci after homologous recombination are shown at the
bottom. B, BamHI; E, EcoRI; H, HindIII; K, KpnI; P, PstI; S1, SalI, neo, neomycin resistance gene; TK, thymidine kinase, E, Exon, P, Primer. (B, F) Detection
of WT and targeted alleles by Southern blot analysis. Ankrd1 (B) and Ankrd23 (F) DNAs from electroporated ES cells were digested with BamHI and
HindIII, respectively and analyzed by Southern blot analysis with probes as shown in A. (C, G) Detection of Ankrd1 (C) or Ankrd23 (G) mRNA by
Northern blot analysis. Aliquots of 10 mg of total RNA isolated from adult ventricles of WT and KO mice were analyzed by using a cDNA probe
spanning the entire coding regions of Ankrd1 and Ankrd23, respectively. A GAPDH probe was used as a control for equal loading. (D, H) Detection of
CARP (D) and DARP (H) protein by Western blot analysis. Protein prepared from adult ventricles of WT and KO mice were analyzed with polyclonal
antibodies against CARP and DARP. Monoclonal antibodies against GAPDH were used as loading control.
doi:10.1371/journal.pone.0093638.g001
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the gradient for the arterial blood pressure between the
constriction was measured by cannulation as described [44]. Only
mice showing an adequate pressure gradient (.50 mmHg) were
included in the analysis. SHAM operated mice were used as
controls.
Statistical Analysis
Data are indicated as average 6 standard deviation. Statistical
comparisons between WT and KO mice were done using the
unpaired Students t-test. A P value of ,0.05 is considered
significant.
Results
Generation of CARP, Ankrd2, and DARP KO Mice
To study the functional role of the muscle ankyrin repeat family
in vivo, mice deficient for each of the three family members,
CARP, Ankrd2, and DARP KO mice were generated. The
generation of Ankrd2 KO mice has been described elsewhere [41].
For each of the three genes, the targeting vector was generated by
replacement of the first 1–3 exons by lacZ and the neomycin
resistance gene (neo), thereby disrupting gene expression (Fig. 1A,
E, and Bean et al [41]). Screening for homologous recombination
in ES cells was performed by Southern blot analysis with primers
as indicated in Fig. 1A, B, E, F, and Bean et al [41]. Correctly
targeted clones were injected into C57/B6 blastocysts and
implanted into the uterus of pseudopregnant mice. The resulting
chimeras were mated to Black Swiss mice and gave rise to
germline transmitted heterozygous mice, which were subsequently
interbred to generate homozygous mice as determined by PCR.
Successful ablation of each of the three genes was confirmed by
Northern (Fig. 1C, G, and Bean et al [41]) and Western blot
analyses (Fig. 1D, H, and Bean et al [41]) using polyclonal
antibodies against CARP, Ankrd2, and DARP. In agreement with
previously published data, Western blot analysis of cardiac and
skeletal muscle lysates revealed highest expression of CARP in
heart, Ankrd2 in skeletal muscle, and DARP in both heart and
skeletal muscle (Fig. 1D, H, and Bean et al [41]).
Generation of MARP Triple KO Mice
CARP, Ankrd2, and DARP KO mice were born at expected
Mendelian ratios, were fertile, and survived till adulthood. KO
mice were indistinguishable from wildtype (WT) littermate control
mice and detailed analyses revealed normal cardiac morphology
and physiology and no significant differences in heart/body weight
ratios (see below). Since the three proteins are highly homologous
in structure and are all expressed in the heart, we hypothesized
that they may have overlapping functions and generated double
and triple MARP KO mice by intercrossing single KO mice. WT
mice generated from these crosses were used as controls to ensure
that KO and WT control mice had the same genetic background.
The successful ablation of all three proteins was confirmed by
PCR as well as Northern and Western blot analyses (Fig. 1C, D,
G, H, and Bean et al [41]).
MARP Triple KO Mice have Normal Cardiac Morphology
MARP triple KO mice were born at expected Mendelian ratios
and were indistinguishable from WT control mice. No statistical
difference in heart/body weight ratios between MARP triple KO
and WT mice was observed and cardiac histological analysis by
hematoxylin and eosin and Masson’s trichrome staining showed
no signs of hypertrophy, infarction, fibrosis, necrosis, calcification,
or fat infiltration in MARP triple KO mice up to 17 months of age
(data not shown).
MARP Triple KO Mice have Normal Cardiac Function
Cardiac function was evaluated noninvasively by echocardiog-
raphy at 4 and 17 months of age. As shown in Table 1 and 2, left
ventricular chamber dimensions, fractional shortening, and heart
rate were normal in MARP triple KO mice compared to WT
control mice. Furthermore, hemodynamic function was evaluated
in 8-week- and 17-month-old mice by cardiac catheterization in
the absence or presence of graded doses of dobutamine, but no
significant difference in contractile function was found between
MARP triple KO and WT mice either at baseline or in the
presence of the b-adrenergic agonist dobutamine (Table 3).
MARP Triple KO Mice Show a Normal Hypertrophic
Response to Transverse Aortic Constriction
It is well known that CARP, Ankrd2, and DARP are
upregulated in response to stress such as cardiac hypertrophy
[5,9,10,12,15]. Therefore, to study the effect of MARP triple KO
on mechanical pressure overload-induced hypertrophy, we per-
formed transverse aortic constriction (TAC) on 4-month-old
MARP triple KO mice and WT control mice. Cardiac function
before and 14 days after TAC was evaluated by echocardiography
and pressure gradients generated by the aortic constriction were
measured. As shown in Table 2, similar pressure gradients were
produced in both groups. Following TAC, left ventricular wall
thickness and mass were increased by similar amounts in both
groups (Table 2), indicating that the response to hypertrophic
stimuli is unaffected in MARP triple KO mice.
Discussion
To study the functional role of the MARP family members
in vivo, we generated CARP, Ankrd2, and DARP KO mice. Since
no phenotype was found in any of the individual KO mice, we
hypothesized that the three highly homologous proteins have
overlapping functions in the heart and generated MARP triple
KO mice. However, in our detailed analyses, we were unable to
detect any significant abnormalities in cardiac development and
basal cardiac function up to 17 months of age and the
hypertrophic response in response to acute pressure overload
induced by TAC was similar between WT and triple KO mice.
On the other hand, transgenic mice with cardiac specific
overexpression of CARP were recently found to show attenuated
cardiac hypertrophy and fibrosis in response to pressure overload
and isoproterenol infusion, although the they were not protected
against heart failure [22]. One explanation for this apparent
discrepancy could be that the constitutive upregulation of CARP
to non-physiological levels in the heart results in non-specific
effects. Alternatively, since the MARP KO mouse models are
constitutive KO mice, it is possible that compensatory mechanisms
counteract the effect of the absence of the MARPs. To clarify this,
it would be necessary to study the effect of conditional KO or
overexpression of the MARP members in adult mice in vivo.
Nevertheless, in light of the strong induction of MARPs in the
heart in response to by various forms of stress, including cardiac
hypertrophy and cardiac disease, as well as an accumulating body
of evidence suggesting important roles of the MARP protein
family in cardiogenesis, gene regulation, sarcomeric stress/stretch
sensing, and disease, it is very surprising that the absence of all
three MARP family members does not appear to have any effect
on cardiac function in vivo, in particular since an increasing
number of mutations in the Ankrd1 gene have been identified in
patients with dilated and hypertrophic cardiomyopathy
[19,20,21]. The most likely explanation for this is that the
identified Ankrd1 mutations have dominant negative effects by
The MARPs Are Not Essential for Cardiac Function
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interfering with the binding of CARP to its many interaction
partners, while complete absence of the MARPs has a less
damaging effect and may be compensated for by other mecha-
nisms. This is for example the case for knockout mice of the Z-line
protein myotilin, which show no phenotype although mutations in
myotilin are causative for limb girdle muscular dystrophy 1A [45].
The lack of a cardiac phenotype in MARP triple KO mice
following 14 days of TAC does not exclude that the MARP KO
mice may show a phenotype after long-term TAC or in response
to other types of stress conditions, such as cardiac ischemia,
myocarditis, and chronic b-adrenergic stimulation. Also, it is
possible that MARPs might play a role in other organs, such as in
skeletal muscle and the vasculature. We previously studied skeletal
muscle function in MARP triple KO mice and found a significant
increase in resting sarcomere length associated with the expression
of longer titin isoforms [42]. Furthermore, MKO mice showed
greater muscle injury following eccentric contraction exercise as
indicated by a greater torque loss, and although they recovered
normally, this was associated with increased expression of the
regulatory genes MyoD and Muscle LIM protein (MLP),
suggesting a role of the MARP family members in regulating
muscle gene expression. In regard to the vasculature, CARP has
Table 1. Echocardiographic analysis on 17-month-old male MARP triple KO mice compared to WT at basal conditions.
WT (n=8) tKO (n=8)
Body weight (g) 5462 4467*
Heart rate (bpm) 540637 558644
LVIDd (mm) 3.9760.18 3.8360.41
LVIDs (mm) 2.2660.27 2.0960.38
IVSd (mm) 0.7860.03 0.7660.04
IVSs (mm) 1.2960.08 1.3060.13
LVPWd (mm) 0.7860.03 0.7860.04
LVPWs (mm) 1.4160.14 1.3360.11
LV FS, % 43.365.0 45.666.2
LVM (mg) 111.666.4 103.8614.2
LVM/BW (mg/g) 2.0860.08 2.3860.40
VCF (circ/s) 9.3761.68 9.8861.60
All data are presented as mean 6 standard deviation. WT, wildtype; tKO, MARP triple knockout; BW, body weight; LVID, left ventricular inner diameter; LVS,
interventricular septum; LVPW, left ventricular posterior wall thickness; LV FS, left ventricular fractional shortening; LVM, left ventricular mass; VCF, velocity of
circumferential fiber shortening; bpm, beats per minute; circ, circumference; d, diastole; s, systole. *P,0.01.
doi:10.1371/journal.pone.0093638.t001
Table 2. Echocardiographic analysis of 4-month-old male MARP triple KO mice compared to WT before and after induction of
cardiac hypertrophy by TAC.
Before TAC 14 days after TAC
WT (n=6) tKO (n=6) WT (n=6) tKO (n=6)
Age (weeks) 18.360 17.360.3 20.660.5 19.760.2
Body weight (g) 36.064.9 37.063.5 36.863.3 36.062.8
Heart rate (bpm) 484681 537655 429642 4406651
LVIDd (mm) 3.7960.19 3.5060.30 3.7760.32 3.6260.49
LVIDs (mm) 2.1660.35 1.9360.24 2.2560.36 2.2160.45
IVSd (mm) 0.7060.07 0.6860.13 0.8460.12 0.8660.14
IVSs (mm) 1.2660.09 1.1960.12 1.4260.10* 1.3660.081
LVPWd (mm) 0.7360.09 0.7160.08 0.8960.15 0.9060.1111
LVPWs (mm) 1.2160.08 1.1660.08 1.4260.10** 1.3660.081
LV FS, % 43.067.6 44.865.9 40.665.3 39.464.7
VCF (circ/s) 8.261.5 9.762.0 6.360.9* 6.360.911
LVMd (mg) 92.468.0 79.0618.4 117.5613.7** 112.267.11
LVM/BW (mg/g) 2.5760.42 2.1360.58 3.1960.39* 3.1260.44
LV/BW (mg/g) 3.9660.44 3.6260.77
PG (mm Hg) 83.8613.2 76.9613.2
See the legend to Table 1 for details and description of abbreviations. TAC, transverse aortic constriction; PG, Pressure gradient. Data comparison was carried out before
and after TAC. *P,0.05 and **P,0.01 for WT TAC vs. WT baseline; 1P,0.05 and 11P,0.01 for KO TAC vs. KO baseline.
doi:10.1371/journal.pone.0093638.t002
The MARPs Are Not Essential for Cardiac Function
PLOS ONE | www.plosone.org 5 April 2014 | Volume 9 | Issue 4 | e93638
been demonstrated to be a downstream target of TGF-b/Smad
signaling in vascular smooth muscle cells and vascular endothelial
cells [46,47], and to be upregulated during arteriogenesis and
angiogenesis, suggesting its involvement in these processes [48,49].
In addition, a role of CARP in the induction of angiogenesis and
neovascularization during wound healing has been proposed
[46,50]. Future studies of the MARP KO mice will reveal whether
the MARPs may play important roles in the vasculature in vivo.
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